• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine

Video

If you only experience migraine with your period for a few days, it would be difficult to recommend taking a drug all the time, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

If you only experience migraine with your period for a few days, it would be difficult to recommend taking a drug all the time, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

Transcript:

The American Journal of Managed Care®(AJMC®): Results from STRIVE found erenumab is a safe and effective option for treating menstrual migraine. Do you think erenumab will be indicated for this condition in the near future?

Dr. Silberstein: There are 2 types of menstrual migraine. There's pure menstrual migraine when women only have migraine with their period and there's menstrual migraine that occurs at any other time. So if you only have migraine with your period for a couple days, I think it would be difficult to recommend taking a drug all the time just for a headache that only occurs 3 days a month. If you have menstrual migraine plus other migraine, and it's intractable, obviously, they should get treatment. There are other treatment options, short-term treatment options, for hormonal treatment for women with pure menstrual migraine.

Related Videos
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Dr Chris Pagnani
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.